Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
HDAX Therapeutics

HDAX Therapeutics

HDAX Therapeutics novel modality unlocks a never-seen-before binding mechanism to key biological molecules.

OverviewStructured DataIssuesContributorsActivity
Is a
Company
Company
Organization
Organization
B2X
B2B
B2B
CEO
‌
Nabanita Nawar
Crunchbase URL
crunchbase.com/organiz...apeutics
Email Address
info@hdaxtx.com
Industry
Life science
Life science
Pharmaceutical industry
Pharmaceutical industry
Biopharmaceutical
Biopharmaceutical
Biotechnology
Biotechnology
Investors
SeedFolio
SeedFolio
‌
FACIT
Toronto Innovation Acceleration Partners (TIAP)
Toronto Innovation Acceleration Partners (TIAP)
Latest Funding Round Date
September 5, 2024
Latest Funding Round Amount (USD)
3,200,000
Latest Funding Type
Seed
Seed
LinkedIn URL
@company/hdaxtx
Location
Toronto, Ontario, Canada
Toronto, Ontario, Canada
Number of Employees (Ranges)
1 – 10
Total Funding Amount (USD)
3,200,000
Official Website
hdaxtx.com

Find more companies like HDAX Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.